| |
| |
|
| Insider
Information: |
Herde Kevin |
| Relationship: |
Chief Financial Officer |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
341,694 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,500,994 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
341,694 |
|
|
| Total
Value |
$3,500,994 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Sorrento Therapeutics Inc |
SRNE |
Executive VP and CFO |
2017-02-03 |
7,000 |
|
0 |
Premium* |
|
|
Maravai Lifesciences Holdings, I... |
MRVI |
Chief Financial Officer |
2024-04-30 |
334,694 |
2021-04-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MRVI |
Maravai Lifesciences Hold... |
Chief Financial Officer |
• – – |
2024-04-30 |
4 |
A |
$5.70 |
$10,146 |
D/D |
1,780 |
334,694 |
0 |
- |
|
| MRVI |
Maravai Lifesciences Hold... |
Chief Financial Officer |
• – – |
2024-03-15 |
4 |
D |
$7.70 |
$66,405 |
D/D |
(8,624) |
332,914 |
0 |
- |
|
| MRVI |
Maravai Lifesciences Hold... |
Chief Financial Officer |
• – – |
2024-02-15 |
4 |
D |
$5.48 |
$14,599 |
D/D |
(2,664) |
341,538 |
0 |
- |
|
| MRVI |
Maravai Lifesciences Hold... |
Chief Financial Officer |
• – – |
2024-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
250,277 |
344,202 |
0 |
- |
|
| MRVI |
Maravai Lifesciences Hold... |
Chief Financial Officer |
• – – |
2023-10-31 |
4 |
A |
$5.83 |
$10,850 |
D/D |
1,861 |
93,925 |
0 |
- |
|
| MRVI |
Maravai Lifesciences Hold... |
Chief Financial Officer |
• – – |
2023-04-28 |
4 |
A |
$11.72 |
$10,243 |
D/D |
874 |
92,064 |
0 |
- |
|
| MRVI |
Maravai Lifesciences Hold... |
Chief Financial Officer |
• – – |
2023-03-15 |
4 |
A |
$0.00 |
$0 |
D/D |
72,507 |
91,190 |
0 |
- |
|
| MRVI |
Maravai Lifesciences Hold... |
Chief Financial Officer |
• – – |
2023-02-15 |
4 |
D |
$15.23 |
$39,766 |
D/D |
(2,611) |
18,683 |
0 |
- |
|
| MRVI |
Maravai Lifesciences Hold... |
Chief Financial Officer |
• – – |
2022-10-31 |
4 |
A |
$14.11 |
$6,745 |
D/D |
478 |
21,294 |
0 |
- |
|
| MRVI |
Maravai Lifesciences Hold... |
Chief Financial Officer |
• – – |
2022-04-29 |
4 |
A |
$22.95 |
$9,800 |
D/D |
427 |
20,816 |
0 |
- |
|
| MRVI |
Maravai Lifesciences Hold... |
Chief Financial Officer |
• – – |
2022-04-29 |
4/A |
A |
$22.95 |
$9,800 |
D/D |
427 |
20,816 |
0 |
- |
|
| MRVI |
Maravai Lifesciences Hold... |
Chief Financial Officer |
• – – |
2022-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
19,500 |
20,389 |
0 |
- |
|
| MRVI |
Maravai Lifesciences Hold... |
Chief Financial Officer |
• – – |
2021-10-31 |
4 |
A |
$22.95 |
$8,996 |
D/D |
392 |
889 |
0 |
- |
|
| MRVI |
Maravai Lifesciences Hold... |
Chief Financial Officer |
• – – |
2021-04-30 |
4 |
A |
$22.95 |
$11,406 |
D/D |
497 |
497 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
Executive VP and CFO |
• – – |
2017-02-03 |
4 |
B |
$5.15 |
$15,450 |
D/D |
3,000 |
7,000 |
2.74 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
Executive VP and CFOOfficer |
• – – |
2016-04-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,000 |
|
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
